Avertix Medical

📍 United States🗓 Founded 2001👥 51 employees💰 Last funded Apr 2019
Medical Equipment Manufacturing🌐 avertix.com
Website LinkedIn
Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we’re dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix’s Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2001
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Avertix Medical?
Avertix Medical has 2 investors on record on gritt.io.
When did Avertix Medical last raise funding?
The most recent investment in Avertix Medical recorded on gritt.io was in April 2019.
When was Avertix Medical founded?
Avertix Medical was founded in 2001.
What industry is Avertix Medical in?
Avertix Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Avertix Medical based?
Avertix Medical is headquartered in United States.